Quest Historical Cash Flow
DGX Stock | USD 163.59 0.30 0.18% |
Analysis of Quest Diagnostics cash flow over time is an excellent tool to project Quest Diagnostics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 309.5 M or Other Cashflows From Financing Activities of 950 K as it is a great indicator of Quest Diagnostics ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Quest Diagnostics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Quest Diagnostics is a good buy for the upcoming year.
Quest |
About Quest Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Quest balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Quest's non-liquid assets can be easily converted into cash.
Quest Diagnostics Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Capital Expenditures
Capital Expenditures are funds used by Quest Diagnostics to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Quest Diagnostics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Quest Diagnostics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Quest Diagnostics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Quest Diagnostics Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. At this time, Quest Diagnostics' Change In Cash is fairly stable compared to the past year. Other Non Cash Items is likely to rise to about 151.5 M in 2024, whereas Free Cash Flow is likely to drop slightly above 719.7 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Capital Expenditures | 403M | 404M | 408M | 289.1M | Dividends Paid | 309M | 305M | 314M | 329.7M |
Quest Diagnostics cash flow statement Correlations
Click cells to compare fundamentals
Quest Diagnostics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Quest Diagnostics cash flow statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | 1.1B | (34M) | (286M) | (557M) | 371M | 389.6M | |
Free Cash Flow | 843M | 1.6B | 1.8B | 1.3B | 864M | 719.7M | |
Change In Working Capital | 35M | 22M | 87M | 119M | (145M) | (152.3M) | |
Begin Period Cash Flow | 135M | 1.2B | 1.2B | 872M | 315M | 309.5M | |
Other Cashflows From Financing Activities | (87M) | (29M) | (159M) | (17M) | 1M | 950K | |
Depreciation | 329M | 361M | 408M | 437M | 439M | 264.3M | |
Other Non Cash Items | (98M) | (59M) | (364M) | 69M | 100M | 151.5M | |
Dividends Paid | 286M | 297M | 309M | 305M | 314M | 329.7M | |
Capital Expenditures | 400M | 418M | 403M | 404M | 408M | 289.1M | |
Total Cash From Operating Activities | 1.2B | 2.0B | 2.2B | 1.7B | 1.3B | 1.0B | |
Net Income | 906M | 1.5B | 2.1B | 1.0B | 850M | 646.8M | |
Total Cash From Financing Activities | 225M | (1.3B) | (2.5B) | (1.7B) | 160M | 168M | |
End Period Cash Flow | 1.2B | 1.2B | 872M | 315M | 686M | 720.3M | |
Stock Based Compensation | 61M | 56M | 97M | 77M | 69.3M | 64.4M | |
Sale Purchase Of Stock | (353M) | (325M) | (2.2B) | (1.4B) | (275M) | (288.8M) | |
Other Cashflows From Investing Activities | (11M) | (354M) | 424M | (139M) | (125.1M) | (131.4M) | |
Change To Liabilities | 102M | 474M | 35M | (180M) | (207M) | (196.7M) | |
Change To Netincome | (27M) | 123M | (257M) | 147M | 169.1M | 164.9M | |
Change To Account Receivables | (63M) | (455M) | 81M | 246M | (15M) | (15.8M) | |
Change To Inventory | 16M | 4M | 29M | (20M) | (23M) | (21.9M) | |
Net Borrowings | 124M | 832M | (805M) | (2M) | (1.8M) | (1.7M) | |
Total Cashflows From Investing Activities | (411M) | (772M) | 21M | (543M) | (488.7M) | (513.1M) | |
Cash And Cash Equivalents Changes | 1.1B | (34M) | (286M) | (557M) | (501.3M) | (476.2M) | |
Cash Flows Other Operating | (4M) | 3M | (323M) | 53M | 61.0M | 64.0M | |
Investments | (411M) | (772M) | 752M | (543M) | (1.1B) | (1.1B) | |
Change Receivables | (63M) | (455M) | 81M | 246M | 282.9M | 297.0M | |
Change To Operating Activities | (4M) | 3M | (9M) | 53M | 61.0M | 64.0M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Quest Stock Analysis
When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.